CL2018001612A1 - Método de terapia fotodinámica (pdt) para el cáncer de vejiga - Google Patents
Método de terapia fotodinámica (pdt) para el cáncer de vejigaInfo
- Publication number
- CL2018001612A1 CL2018001612A1 CL2018001612A CL2018001612A CL2018001612A1 CL 2018001612 A1 CL2018001612 A1 CL 2018001612A1 CL 2018001612 A CL2018001612 A CL 2018001612A CL 2018001612 A CL2018001612 A CL 2018001612A CL 2018001612 A1 CL2018001612 A1 CL 2018001612A1
- Authority
- CL
- Chile
- Prior art keywords
- bladder cancer
- photodynamic therapy
- pdt
- therapy method
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/307—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the urinary organs, e.g. urethroscopes, cystoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/061—Bladder and/or urethra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Radiation-Therapy Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15200938 | 2015-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2018001612A1 true CL2018001612A1 (es) | 2019-01-11 |
Family
ID=55066354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018001612A CL2018001612A1 (es) | 2015-12-17 | 2018-06-14 | Método de terapia fotodinámica (pdt) para el cáncer de vejiga |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11235168B2 (enExample) |
| EP (1) | EP3389716B1 (enExample) |
| JP (1) | JP6995755B2 (enExample) |
| KR (1) | KR102787192B1 (enExample) |
| CN (2) | CN119345612A (enExample) |
| AU (1) | AU2016372575B2 (enExample) |
| BR (1) | BR112018011965A2 (enExample) |
| CA (1) | CA3008552C (enExample) |
| CL (1) | CL2018001612A1 (enExample) |
| DK (1) | DK3389716T3 (enExample) |
| ES (1) | ES2910034T3 (enExample) |
| IL (1) | IL259925B (enExample) |
| MX (1) | MX385912B (enExample) |
| PL (1) | PL3389716T3 (enExample) |
| RU (1) | RU2745194C2 (enExample) |
| SG (1) | SG11201805000RA (enExample) |
| WO (1) | WO2017103285A1 (enExample) |
| ZA (1) | ZA201804530B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016372575B2 (en) * | 2015-12-17 | 2022-12-08 | Photocure Asa | Method of photodynamic therapy (PDT) for bladder cancer |
| CN110420326A (zh) * | 2019-09-17 | 2019-11-08 | 上海复旦张江生物医药股份有限公司 | 一种多替泊芬的应用 |
| KR20240011794A (ko) * | 2021-08-17 | 2024-01-26 | 보스톤 싸이엔티픽 싸이메드 인코포레이티드 | 광활성제의 활성화를 위한 디바이스, 시스템 및 방법 |
| AU2024231397A1 (en) | 2023-03-07 | 2025-09-25 | Photocure Asa | Therapy for bladder cancer |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ291132B6 (cs) | 1995-03-10 | 2002-12-11 | Photocure Asa | Estery kyselin 5-aminolevulových a farmaceutický prostředek s jejich obsahem |
| US7530461B2 (en) | 1995-03-10 | 2009-05-12 | Photocure Asa | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| US20050003154A1 (en) * | 2002-12-13 | 2005-01-06 | White Gary L. | Laminated building panels having preselected colors |
| GB0406917D0 (en) | 2004-03-26 | 2004-04-28 | Photocure Asa | Compounds |
| GB0700580D0 (en) | 2007-01-11 | 2007-02-21 | Photocure Asa | Use |
| GB0724279D0 (en) | 2007-12-12 | 2008-01-23 | Photocure Asa | Use |
| CN101891639A (zh) * | 2009-05-20 | 2010-11-24 | 上海先导化学有限公司 | 一种制备5-氨基酮戊酸盐酸盐的方法 |
| CN102458388B (zh) | 2009-06-11 | 2016-09-28 | 光治疗Asa公司 | 半固体组合物及药物制品 |
| CN102802612A (zh) | 2009-06-11 | 2012-11-28 | 光治疗Asa公司 | 含有5-氨基酮戊酸的固态组合物 |
| RU2448745C2 (ru) * | 2010-05-31 | 2012-04-27 | Олег Феликсович Каган | Способ лечения поверхностного рака мочевого пузыря |
| EP2793679B1 (en) * | 2011-12-19 | 2017-05-17 | Technical University of Denmark | An illumination system for endoscopic applications |
| WO2014020164A1 (en) * | 2012-08-03 | 2014-02-06 | Photocure Asa | Compounds |
| GB201221123D0 (en) * | 2012-11-23 | 2013-01-09 | Photocure As | Device for photodynamic treatment |
| AU2016372575B2 (en) * | 2015-12-17 | 2022-12-08 | Photocure Asa | Method of photodynamic therapy (PDT) for bladder cancer |
-
2016
- 2016-12-19 AU AU2016372575A patent/AU2016372575B2/en active Active
- 2016-12-19 BR BR112018011965A patent/BR112018011965A2/pt not_active Application Discontinuation
- 2016-12-19 CA CA3008552A patent/CA3008552C/en active Active
- 2016-12-19 EP EP16810437.0A patent/EP3389716B1/en active Active
- 2016-12-19 ES ES16810437T patent/ES2910034T3/es active Active
- 2016-12-19 SG SG11201805000RA patent/SG11201805000RA/en unknown
- 2016-12-19 WO PCT/EP2016/081809 patent/WO2017103285A1/en not_active Ceased
- 2016-12-19 DK DK16810437.0T patent/DK3389716T3/da active
- 2016-12-19 PL PL16810437T patent/PL3389716T3/pl unknown
- 2016-12-19 JP JP2018532037A patent/JP6995755B2/ja active Active
- 2016-12-19 KR KR1020187020005A patent/KR102787192B1/ko active Active
- 2016-12-19 RU RU2018123834A patent/RU2745194C2/ru active
- 2016-12-19 CN CN202411499253.8A patent/CN119345612A/zh active Pending
- 2016-12-19 MX MX2018007166A patent/MX385912B/es unknown
- 2016-12-19 CN CN201680079638.6A patent/CN108697800A/zh active Pending
- 2016-12-19 US US16/063,142 patent/US11235168B2/en active Active
-
2018
- 2018-06-10 IL IL259925A patent/IL259925B/en unknown
- 2018-06-14 CL CL2018001612A patent/CL2018001612A1/es unknown
- 2018-07-06 ZA ZA2018/04530A patent/ZA201804530B/en unknown
-
2022
- 2022-01-31 US US17/588,978 patent/US11980772B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019501161A (ja) | 2019-01-17 |
| KR20180094986A (ko) | 2018-08-24 |
| BR112018011965A2 (pt) | 2018-12-04 |
| KR102787192B1 (ko) | 2025-03-25 |
| ES2910034T3 (es) | 2022-05-11 |
| US20220152411A1 (en) | 2022-05-19 |
| US11235168B2 (en) | 2022-02-01 |
| EP3389716B1 (en) | 2022-03-23 |
| MX385912B (es) | 2025-03-18 |
| RU2745194C2 (ru) | 2021-03-22 |
| CN119345612A (zh) | 2025-01-24 |
| US20190022404A1 (en) | 2019-01-24 |
| AU2016372575A1 (en) | 2018-07-12 |
| NZ743697A (en) | 2024-10-25 |
| ZA201804530B (en) | 2019-09-25 |
| IL259925A (en) | 2018-07-31 |
| CN108697800A (zh) | 2018-10-23 |
| DK3389716T3 (da) | 2022-04-11 |
| RU2018123834A3 (enExample) | 2020-04-13 |
| EP3389716A1 (en) | 2018-10-24 |
| SG11201805000RA (en) | 2018-07-30 |
| WO2017103285A1 (en) | 2017-06-22 |
| PL3389716T3 (pl) | 2022-06-20 |
| AU2016372575B2 (en) | 2022-12-08 |
| CA3008552C (en) | 2024-01-02 |
| US11980772B2 (en) | 2024-05-14 |
| RU2018123834A (ru) | 2020-01-17 |
| CA3008552A1 (en) | 2017-06-22 |
| IL259925B (en) | 2022-04-01 |
| JP6995755B2 (ja) | 2022-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020000299A1 (es) | Compuestos, composiciones y métodos. | |
| MX2018005315A (es) | Composiciones y metodos para el tratamiento del cancer. | |
| DOP2019000180A (es) | INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS | |
| MX2016013457A (es) | Inhibidores de mdm2 y metodos terapeuticos que utilizan el mismo. | |
| EA201691866A1 (ru) | Проникающие в опухоль лимфоциты для адоптивной клеточной терапии | |
| AR102553A1 (es) | Terapia de combinación con agonistas de unión ox40 e inhibidores de tigit | |
| CL2016002027A1 (es) | Ciclopropilamina como inhibidor de la lsd1 | |
| AR106582A1 (es) | Formulaciones subcutáneas de anticuerpos anti-cd38 y sus usos | |
| MX2019007276A (es) | Composiciones y métodos para mejora o aumento de la producción de ifn tipo i. | |
| CL2018003123A1 (es) | Terapia de combinación para el tratamiento del cáncer | |
| EA201591674A1 (ru) | Противораковые вакцины и способы лечения с их применением | |
| MX2015017312A (es) | Suministro y uso de composiciones, vectores y sistemas crispr-cas para la modificación dirigida y terapia hepáticas. | |
| MX2017016681A (es) | Uso de compuestos de cloroquina y clemizol para el tratamiento de afecciones inflamatorias y cancerosas. | |
| CL2018001612A1 (es) | Método de terapia fotodinámica (pdt) para el cáncer de vejiga | |
| MX383484B (es) | Método para tratar el cáncer. | |
| CR20180228A (es) | Terapia adjunta con 25-hidroxi vitamina d y articulos de la misma | |
| MX2016015437A (es) | Combinacion que comprende un glucocorticoide y edo-s101. | |
| CL2018002793A1 (es) | Terapia de cáncer con un virus oncolítico combinado con un inhibidor de puntos de control | |
| AR112102A1 (es) | Tinostamustina para utilizar en el tratamiento de cáncer de ovario | |
| MX2017011500A (es) | Combinaciones y formulaciones de dosis fijas que comprenden ácido 8-hidroxi-2,2,14,14- tetrametilpentadecanodioico (etc1002) y una o más estatinas y métodos para tratar o reducir el riesgo de enfermedad cardiovascular. | |
| AR112144A1 (es) | Compuestos para el tratamiento del sarcoma | |
| CL2017002299A1 (es) | Combinaciones de dosis fija y formulaciones comprendiendo etc-1002 y ezetimiba y métodos para tratar o reducir el riesgo de enfermedades cardiovasculares | |
| CO2020001107A2 (es) | Moduladores terapéuticos del modo inverso de la atp sintasa | |
| CL2016001746A1 (es) | Derivados de hidroxi formamida y sus usos | |
| CL2021000950A1 (es) | Anticuerpos contra el lif y usos de los mismos (divisional de la solicitud no. 201901717) |